Literature DB >> 15763458

Incidental lung cancers identified at coronial autopsy: implications for overdiagnosis of lung cancer by screening.

Renee L Manser1, Malcolm Dodd, Graham Byrnes, Louis B Irving, Donald A Campbell.   

Abstract

BACKGROUND: The extent to which overdiagnosis occurs in lung cancer screening programmes has been debated. Overdiagnosis refers to the detection by screening of cancers that would not have become clinically apparent or symptomatic before that individual died of other causes.
METHODS: A retrospective review of coronial autopsies performed in Victoria between April 1991 and February 2002 was conducted to determine the rate of incidental lung cancer in individuals who died of natural causes.
RESULTS: A total of 24,708 autopsy reports were searched electronically. We estimated that in 56% of these death was from natural causes. Amongst individuals who died naturally there were 167 cases of lung cancer, 47 of these were incidental including five carcinoid tumours, three small cell tumours, 11 cases of carcinoma in situ and 28 invasive nonsmall cell lung cancers. Of the incidental invasive nonsmall cell lung cancers, 86% were stage I.
CONCLUSIONS: Although incidental lung cancer is uncommon, there are some lung cancers that remain undetected during life and do not contribute to death. These findings support the hypothesis that some lung cancers detected by screening may never progress to cause symptoms or death in that individual's lifetime and therefore may be overdiagnosed by screening.

Entities:  

Mesh:

Year:  2005        PMID: 15763458     DOI: 10.1016/j.rmed.2004.08.017

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  13 in total

Review 1.  Lung cancer screening: an update, discussion, and look ahead.

Authors:  Peter J Mazzone
Journal:  Curr Oncol Rep       Date:  2010-07       Impact factor: 5.075

2.  Is screening for lung cancer using low dose spiral CT scanning worthwhile?

Authors:  F V Gleeson
Journal:  Thorax       Date:  2006-01       Impact factor: 9.139

Review 3.  Lung cancer screening.

Authors:  Peter J Mazzone; Tarek Mekhail
Journal:  Curr Oncol Rep       Date:  2007-07       Impact factor: 5.075

Review 4.  Tumor Dormancy and Relapse: From a Natural Byproduct of Evolution to a Disease State.

Authors:  Masoud H Manjili
Journal:  Cancer Res       Date:  2017-05-15       Impact factor: 12.701

5.  Screening for lung cancer with low-dose computed tomography: a systematic review and meta-analysis of the baseline findings of randomized controlled trials.

Authors:  Muralikrishna Gopal; Shaad E Abdullah; James J Grady; James S Goodwin
Journal:  J Thorac Oncol       Date:  2010-08       Impact factor: 15.609

Review 6.  Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression.

Authors:  Mina J Bissell; William C Hines
Journal:  Nat Med       Date:  2011-03       Impact factor: 53.440

Review 7.  Reframing How Physical Activity Reduces The Incidence of Clinically-Diagnosed Cancers: Appraising Exercise-Induced Immuno-Modulation As An Integral Mechanism.

Authors:  Annabelle Emery; Sally Moore; James E Turner; John P Campbell
Journal:  Front Oncol       Date:  2022-03-14       Impact factor: 6.244

8.  Addressing overdiagnosis and overtreatment in cancer: a prescription for change.

Authors:  Laura J Esserman; Ian M Thompson; Brian Reid; Peter Nelson; David F Ransohoff; H Gilbert Welch; Shelley Hwang; Donald A Berry; Kenneth W Kinzler; William C Black; Mina Bissell; Howard Parnes; Sudhir Srivastava
Journal:  Lancet Oncol       Date:  2014-05       Impact factor: 41.316

9.  Clinical characteristics and prognosis of incidentally detected lung cancers.

Authors:  S Quadrelli; G Lyons; H Colt; D Chimondeguy; A Buero
Journal:  Int J Surg Oncol       Date:  2015-02-03

10.  Frequency and Significance of Pathologic Pulmonary Findings in Postmortem Examinations-A Single Center Experience before COVID-19.

Authors:  Sabina Berezowska; Andreas Schmid; Tereza Losmanová; Mafalda Trippel; Annika Blank; Yara Banz; Stephan M Jakob; Rupert Langer
Journal:  Diagnostics (Basel)       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.